VC investment in New England medtech companies bucks national decline trend

11/12/2013 | American City Business Journals

Data from the National Venture Capital Association indicated that medtech companies in the New England area secured $505 million in venture capital financing from 46 deals last year, the highest such investment posted in the area over the past 10 years. This was in contrast to the national trend in which the medtech sector saw a 40% decline in VC investment over five years. The report also noted that 2013 numbers are on track to match last year's financing levels.

View Full Article in:

American City Business Journals

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Director, Senior Legal Counsel
Alcon
Fort Worth, TX
Senior Scientist - Cell Engineering Group
Pfizer
San Francisco, CA
Associate Director, Compliance Business Partner I
Boehringer Ingelheim
Ridgefield, CT
Attorney
U.S. DEPARTMENT OF HEALTH & HUMAN SERVICES Food and Drug Administration Office of the Chief Counsel
Silver Spring, MD, MD
Counsel – Regulatory Affairs
RAI Services Company
Winston Salem, NC